ah 6809 has been researched along with taprostene in 1 studies
Studies (ah 6809) | Trials (ah 6809) | Recent Studies (post-2010) (ah 6809) | Studies (taprostene) | Trials (taprostene) | Recent Studies (post-2010) (taprostene) |
---|---|---|---|---|---|
163 | 1 | 49 | 55 | 12 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allison, S; Hoang, KG; Murray, M; Petrovic, N | 1 |
1 other study(ies) available for ah 6809 and taprostene
Article | Year |
---|---|
Prostanoids regulate angiogenesis acting primarily on IP and EP4 receptors.
Topics: Benzyl Compounds; Cell Movement; Dinoprostone; Endothelial Cells; Epoprostenol; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Neovascularization, Pathologic; Neovascularization, Physiologic; Prostaglandins I; Real-Time Polymerase Chain Reaction; Receptors, Epoprostenol; Receptors, G-Protein-Coupled; Receptors, Prostaglandin E, EP4 Subtype; Thiophenes; Triazoles; Xanthones | 2015 |